Quantcast
Home / Practice Areas / Personal Injury and Tort / Pfizer ordered to pay $142M for Neurontin marketing fraud

Pfizer ordered to pay $142M for Neurontin marketing fraud

BOSTON - A federal jury Thursday found that Pfizer violated anti-racketeering laws in promoting its epilepsy drug Neurontin for unapproved uses and must pay at least $142 million in damages.